Sign Up Today and Learn More About Windward Bio Stock
Invest in or calculate the value of your shares in Windward Bio or other pre-IPO companies through EquityZen's platform.
Windward Bio Stock
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
About Windward Bio Stock
Founded
2024
Industries
Software, Artificial Intelligence, Data and Analytics
Windward Bio Press Mentions
Stay in the know about the latest news on Windward Bio
Kelun-Biotech Partner Windward Bio Announces First Patients Dosed in Phase 2 SIRIUS COPD Study of SKB378/WIN378
biospace • Jun 09, 2026
First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody
biospace • Jun 09, 2026
Kelun-Biotech Partner Windward Bio Announces First Patients Dosed in Phase 2 SIRIUS COPD Study of SKB378/WIN378
en • Jun 09, 2026
First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody
prnewswire • Jun 09, 2026
First Patients Dosed in Phase 2 SIRIUS COPD Study of HBM9378/WIN378, a Fully Human Ultra Long-Acting Anti-TSLP Antibody
en • Jun 09, 2026
Windward Bio Management
Leadership team at Windward Bio
Board Member
David Bonita
Board Member
Naveed Siddiqi
Join now and verify your accreditation status to gain access to:
- Windward Bio Current Valuation
- Windward Bio Stock Price
- Windward Bio Management
- Available deals in Windward Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Windward Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Windward Bio Revenue and Financials
- Windward Bio Highlights
- Windward Bio Business Model
- Windward Bio Risk Factors
- Windward Bio Research Report from SACRA Research
Trading Windward Bio Stock
How to invest in Windward Bio stock?
Accredited investors can buy pre-IPO stock in companies like Windward Bio through EquityZen funds. These investments are made available by existing Windward Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Windward Bio stock?
Shareholders can sell their Windward Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 460K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 54K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."